Company Information

  

Address: 18TH FL, JIALONG INTERNATIONALBUILDING
19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT 
City: BEIJING 
State:  
Zip Code: 100125 
Telephone: 86-10-6598-3111 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

We are a biopharmaceutical company principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products, or plasma products, in China. We are among the top three producers of plasma products in China in terms of 2016 sales, based on our industry knowledge. We operate our business through a majority owned subsidiary, Shandong Taibang, a company based in Tai'an, Shandong Province and a wholly owned subsidiary, Guizhou Taibang, a company based in Guiyang, Guizhou Province. We also hold a minority equity interest in Huitian, a plasma products company based in Xi'an, Shaanxi Province. We have a strong product portfolio with over 20 different dosage forms of plasma products and other biopharmaceutical products across nine categories. All of our products are prescription medicines administered in the form of injections. Our principal products are human albumin and immunoglobulin for intravenous injection, or IVIG.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/20173.84NA29.45
03/20173.86NA25.94

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity2.14Total Liab/Total Assets0.24
Net Inc/Total Assets0.17Total Liab/Inv Cap0.27
Net Inc/Inv Cap0.20Total Liab/Comm Equity2.91
Pretax Inc/Net Sales0.45Interest Coverage Ratio605.86
Net Inc/Net Sales0.31Curr Debt/EquityNA
Cash Flow/Net Sales0.36LTD/EquityNA
SG&A/NetSales0.19Total Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables Turnover11.55Quick Ratio3.23
Inventory Turnover0.88Current Ratio5.36
Inventory Day Sales0.00Net Rec/Curr Assets0.09
Net Sales/Work Cap1.07Inv/Curr Assets0.40
Net Sales/PP&E2.58  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 89.28 91.45 77.63 86.53
Cost of Goods Sold 30.11 32.22 30.86 27.65
Selling & Admin Exps 17.84 19.06 19.93 18.11
Operating Income 39.40 38.82 23.26 39.72
Interest Exp 0.29 0.06 0.02 0.06
Pretax Income 41.70 41.29 27.53 42.55
Other Income 1.62 1.62 2.91 1.79
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 31.03 29.99 19.44 28.39

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 223.24 197.36 183.77 203.20
Receivables - Total 61.15 51.65 33.92 46.18
Inventories - Total 183.26 166.38 156.41 146.94
Total Current Assets 485.29 433.12 393.37 434.87
Net Property, Plant & Equipment 145.41 138.04 132.09 134.42
Total Assets 718.20 655.42 604.96 650.25
Liabilities        
Accounts Payable 78.63 75.61 73.44 72.40
Debt in Current Liabilities 14.47 8.70 NA NA
Total Current Liabilities 93.09 84.31 73.44 72.40
Long-Term Debt NA NA NA NA
Total Liabilities 166.22 152.64 142.76 174.30
Stockholder's Equity        
Minority Interest 62.94 58.08 58.94 91.02
Preferred Stock NA NA NA NA
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings 499.51 468.48 438.48 419.05
Treasury Stock -56.43 -56.43 -56.43 -56.43
Total Stockholders' Equity 551.99 502.78 462.20 475.95
Total Liabilities and Stockholders' Equity 718.20 655.42 604.96 650.25

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities 23.86 13.03 35.94 30.30
Net Cash Provided by Investing Activities -7.53 -9.08 -8.44 -17.74
Net Cash Provided by Financing Activities 5.99 8.81 -41.63 -12.65

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/2012184.8145.22--
12/2013203.3654.60--
12/2014243.2570.92--
12/2015296.4689.04--
12/2016341.17104.78--
Growth Rates16.5623.38--

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1714319,93073.17




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.